Anti-HIV agents.  Raltegravir (Isentress)--results after  one year.
D000328:Adult; D018791:CD4 Lymphocyte Count; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009930:Organic Chemicals / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D019562:Viral Load
D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D010919:Placebos; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium